Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, September 27, 2016
OPKO Health, Inc. has announced the appointment of Benjamin D. Solomon, M.D. as Managing Director of GeneDx, effective as of October 3, 2016. GeneDx, part of OPKO’s BioReference Laboratories subsidiary, specializes in genetic testing for rare ...
read more
OPKO Health has announced the appointment of Gregory Henderson, M.D., Ph.D., as President of Bio-Reference Laboratories (BRL), effective immediately.
read more
Wednesday, February 01, 2017
OPKO Health has announced that its subsidiary and business unit, GeneDx, is entering into a collaboration with the Deciphering Developmental Disorder (DDD) study led by the Wellcome Trust Sanger Institute.
read more
Wednesday, October 31, 2012
Overcoming the challenges of conducting China’s largest outcomes trial and how it relates to doing business in this vital emerging market will be the topic of a joint presentation by Anja Moellman, Senior Project Director for Theorem Clinical ...
read more
OpSec Security has announced a COVID-19 testing kit authentication and traceability solution.
read more
Thursday, August 31, 2023
Optibrium, a developer of software and AI solutions for drug discovery, announced the acquisition of BioPharmics LLC, expanding its 3D drug design and modelling offering. Bringing decades of experience in computational chemistry and biology, ...
read more
Optibrium Ltd and BioPharmics LLC, leading providers of software and computational solutions for drug discovery, announce their partnership. Industry-leading 3D ligand-based design approaches from BioPharmics will be available in Optibrium’s small ...
read more
Tuesday, January 17, 2023
Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the appointment of Steve Yemm as Chief Commercial Officer (CCO), the latest in a series of senior-level hires as the Company rapidly expands.
read more
Optibrium announced the introduction of its Augmented Chemistry™ services, which provide collaborators with novel artificial intelligence technologies to supplement their skills and experience, enabling them to make more effective decisions and ...
read more
Optibrium Limited, a provider of software and artificial intelligence (AI) solutions for drug discovery, announced the publication of a peer-reviewed study in Applied AI letters “Deep Imputation on Large-Scale Drug Discovery Data”.
read more
Optimal Just-in-Time and CTCA are collaborating to speed patient enrollment in oncology clinical trials.
read more
Tuesday, December 01, 2015
Optimal Research, a clinical research site solution provider, has announced the addition of a 40 bed Phase I inpatient facility in Austin, TX.
read more
OptimizeRx has launched TelaRep™, its latest EHR-enabled digital health tool designed to support physicians who are treating patients with specialty drug therapies.
read more
Wednesday, March 11, 2020
OptimizeRx has secured two additional enterprise-level engagements, expanding access for two clients across the entire OptimizeRx platform.
read more
Optum and Merck will collaborate to develop and simulate the performance of contractual reimbursement models in which payment for prescription drugs is aligned more closely with patient health outcomes.
read more